BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 3372263)

  • 1. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
    Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
    Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM.
    Erlich HA; Bugawan TL; Scharf S; Nepom GT; Tait B; Griffith RL
    Diabetes; 1990 Jan; 39(1):96-103. PubMed ID: 2210066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
    Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes mellitus: HLA-DQ alpha complements HLA-DQ beta.
    Baisch JM; O'Brien ME; Hoover ML; Capra JD
    Scand J Immunol; 1992 Aug; 36(2):321-30. PubMed ID: 1502499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
    Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
    Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
    Robinson DM; Holbeck S; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
    Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
    Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
    Michelsen B; Lernmark A
    J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility.
    Khalil I; Deschamps I; Lepage V; al-Daccak R; Degos L; Hors J
    Diabetes; 1992 Mar; 41(3):378-84. PubMed ID: 1551498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships.
    Carrier CM; Mollen N; Rothman WC; Rodriguez de Cordoba S; Rey-Campos J; Ginsberg-Fellner F; Carpenter C; Rubinstein P
    Hum Immunol; 1989 Jan; 24(1):51-63. PubMed ID: 2563360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population.
    Vicario JL; Martinez-Laso J; Corell A; Martin-Villa JM; Morales P; Lledo G; Segurado OG; de Juan D; Arnaiz-Villena A
    Diabetologia; 1992 May; 35(5):475-81. PubMed ID: 1355747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus.
    Monos DS; Mickelson E; Hansen JA; Baker L; Zmijewski CM; Kamoun M
    Hum Immunol; 1988 Dec; 23(4):289-99. PubMed ID: 3266208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
    Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
    Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
    Sheehy MJ
    Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of the HLA-DR beta and HLA-DQ beta loci from three Pemphigus vulgaris patients.
    Scharf SJ; Long CM; Erlich HA
    Hum Immunol; 1988 May; 22(1):61-9. PubMed ID: 3391803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM).
    Yasunaga S; Kimura A; Hamaguchi K; Ronningen KS; Sasazuki T
    Tissue Antigens; 1996 Jan; 47(1):37-48. PubMed ID: 8929711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetics of disease susceptibility: new perspectives in HLA.
    Nepom GT; Seyfried CA; Nepom BS
    Pathol Immunopathol Res; 1986; 5(1):37-46. PubMed ID: 3774753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.